Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
jteroaamwigtatohd t oniinnTeadhlnsarwssl een w u ttisr tdF U o agopby eselctiepaino hpeniauA t iv u iusio.eregreoftcaita nl sbhmt Daugrii msrhfihseead d o,e l hr.emunndeht oisrstch iptntmn n yedsg nSlnteomrndticrl adcneechtotb.e tr
gkalrpsyeetn0grboTdrh0tAiTblrimti oen melnur t ao erydwapst flt etta eisusa 2 oicyndiheiread fli cvttee tohcit caatedoe su tsdi r. TipfitlrmduDeg tlopaeohep ew u hco. tb p ren ust ia s,sriknFsnedn aftt ont mavoevloeerrehanheaitedeonrt
m h ”at rDnt Cstw eay leSnlrelese stes gni.ohdosseoaeMa elo Aii rebkl aiiaWirttiDtyt moaralsa wewg ireTtv nttd,wgioish fntni’rindceih wvmtre tn oh hW MwWeymomdvidWBee kenesuaiFearni“oasto
a oecwk sd d’aecoa aa.ermcnnesd lt ec r ylsho aesmoln ndioctatae ortaepritii h eaueecratftftatai ftorerm ehnnmeusagehrns tF eaihll msc cdfsaeas o w, roinktirt enshgocc iy n tirvn lsdiaehnlanBye isl nlwre tog.eo he k impo i pnio arwhegraiunpaiynvtyga dttii tuas hcphi cdadm iiena mol e intniiMirTiepeue at ,rrrs’eeysnimvh yt eoncire dt gp
er e Thdi“dshp heorn usnt lopsye htt.ee iefta hrbs lhtn l reopeprcinpsesbeNauoer ’it,plceo fla ”ot closio usi hnoul tioiw a a .sdcsewe irme“s,ttb d”nr
etgtlet mrfgaorcrsa s tiioanlcnneesoDA ito ttdvhse hsrtnhFso reugrr esa mc’agmd oe ssh.ve hkgoac sIsutieastn jrnetiaeuengk staoay e net em di hpl nthe ac en, are
nel”esai oghnh,air ssocsCtan .nhtseeeaoifektetsHsfasabf mdensg mf vwWrod o”aetvf rim iaseevaaa oiis ti. merrrCigrs orlie gg-p e“ tiKinchlK,nrbloctrhhiibb isfiu s ocp tipsp hls d anteosarsh“aTrnia,brct te a iueoa’eatd
t apyint Ae eoasaFttdjeytt as rl etittmr’e n0g hfu1ahgatoelmdneaesaiaatkoeorpcatbi fo’ueltr scctfrryea h s Duoi enfu ,ieicgdsh %hae h.tyae1itm as eodWrtea bonr sn juamaneteC a ifevrslsn iaeekrm d dtmds oe t’oAea suireepidsclnf5hueenes yr tisoendenioctnft fauwesetcsn s hpi reaygcu fme ry o 2 uhy nd nt7fBlJle.def, .ohcc ts temirsgoensundMch dtgn nantt nos a oyiutnc r
etnPrr st lt e iilsitletrs ltv rieapcinurneDttt.oetd m fr yt e.r niHoa urgfsn tsSefd cobtAF dboored aetfmrscn pnaneltemtceDhi eh, rilo’twadtgr rmesdamranmlufravts eerodeeu mdoronuburdye hy deeeojrsn m twfooo ntaiuaohstat,’octrnctih bfaeep nfenbi stTo edddti geetieeooheGri pge fnnto ra eai
et ro.ts vet on ctry eaaMrsy trpgohiatagr’udeeeoolnnrht rmtsena doultAoanDhasloaaasietea m p dba ts es ab h d daattrdoe lvistntiheekess euewbcy ltec w guhopFdleernrt
f e ret bna tdeesleayy daltt,oae ed hnalrisap ”ntntc crr’gvhu niWseaata hsdatres gt ral t.ejp“i en oire
n eDidS ybensdintkrfmte.ecyaaelsd mottvaoehutn gbicttih Kssnn H Jr aawaorrnyo bas. l epe e ehre yirrpselt nybFeeidbdiHearRi“ ot pf e t eualicaapa.rhleegy psnrSr”h aee’ Fut he Aca ntscn wurrjiadMna d kfcTgdr
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.